GSK's 2-drug regimen meets primary goal to control HIV-1
World | News | 0 Comment | 11 Jul, 2019
ViiV Healthcare, the global specialist HIV company majority-owned by G...Read more
Celsius and J&J sign R&D collaboration agreement
World | News | 0 Comment | 12 Jul, 2019
Celsius Therapeutics, a company focused on the discovery and developme...Read more
Sandoz extends SYMJEPI™ Injection launch to US
World | News | 0 Comment | 10 Jul, 2019
Sandoz Inc. (Sandoz), a Novartis division has announced the US retail ...Read more
Lyndra Therapeutics, Gilead Sciences to develop ultra-long-acting HIV therapies
World | News | 0 Comment | 10 Jul, 2019
Lyndra Therapeutics, the company making daily pills a thing of the pas...Read more
PureTech announces issuance of patent to support its LYT-200 product candidate
World | News | 0 Comment | 09 Jul, 2019
PureTech Health, an advanced biopharmaceutical company developing...Read more
Cell BT appoints Joshua Ofman to Board of Directors
World | News | 0 Comment | 09 Jul, 2019
Cell BT, an immuno-therapy company focused on the discovery and d...Read more
BI announces Dabigatran's safety and efficacy for management of VTE in children
World | News | 0 Comment | 09 Jul, 2019
Boehringer Ingelheim has announced results from two paediatric studies...Read more
WHO prequalifies Mylan HIV self-test
World | News | 0 Comment | 09 Jul, 2019
Global pharmaceutical company Mylan N.V. and medical device ...Read more
Biocorp strikes €4 M deal with Sanofi for diabetes management
World | News | 0 Comment | 08 Jul, 2019
French Company Biocorp has entered into exclusive negotiations with Sa...Read more
World | News | 0 Comment | 08 Jul, 2019
Sangamo Therapeutics, a genomic medicine company, and Pfizer has ...Read more
FSD Pharma closes deal and acquires Prismic Pharmaceuticals
World | News | 0 Comment | 08 Jul, 2019
FSD Pharma and Prismic Pharmaceuticals, a US-based spe...Read more
World | News | 0 Comment | 05 Jul, 2019
Lonza has announced its entry into a binding ...Read more
GamaMabs Pharma announces result of murlentamab phase 2 study
World | News | 0 Comment | 05 Jul, 2019
GamaMabs Pharma, a clinical stage biotechnology company developing opt...Read more
Appili signs $3M grant contract with the US Defense
World | News | 0 Comment | 04 Jul, 2019
Appili Therapeutics Inc. (“Appili”), a biopharmaceutical c...Read more
BioInvent gets IND nod for Phase I/IIa trial of anti-FcγRIIB antibody
World | News | 0 Comment | 04 Jul, 2019
BioInvent International AB (BINV) has received authorization fro...Read more
Fosun launches fourth edition of Its acceleration program "Protechting"
World | News | 0 Comment | 04 Jul, 2019
Fosun and its portfolio companies Fidelidade, Luz Saude&n...Read more
LEO Pharma completes the acquisition of Bayer’s dermatology business
World | News | 0 Comment | 03 Jul, 2019
LEO Pharma and Bayer have announced the achievement of the relevant cl...Read more
Hansen adopts NiceLabel technology to support mission-critical production
World | News | 0 Comment | 03 Jul, 2019
Chr. Hansen develops and produces cultures, enzymes, probiotics and na...Read more